“Now is the time that we combine forces to relieve people with diabetes on insulin from the burden of managing daily blood glucose highs and lows.”

Bastiaan de Galan, MELISSA Coordinator
Universiteit Maastricht, The Netherlands

“A unique opportunity to offer a validated solution for personalized treatment to all patients who do not have the privilege to be equipped with a closed loop.”

Stephan Proennecke, Project Manager & Director
Industrialization at Debiotech S.A., Switzerland

“Transparent, trustworthy, validated, and unbiased AI tools have the potential to transform and revolutionise diabetes management.”

Prof. Dr Stavroula Mougiakakou, AI in Health and Nutrition Laboratory
ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland